Home / Drug shortages / Hydromorphone Hydrochloride Injection

Hydromorphone Hydrochloride Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Hydromorphone Hydrochloride Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 11/01/2017. Reported reason: Demand increase for the drug

Shortage Details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0641-6254-01
Dosage Form
Injection
Presentation
Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-6254-01)
Initial Posting
11/01/2017
Revised Date

Reason

Demand increase for the drug

FDA data resources